The treatment of metastatic colorectal cancer : an overview - review

Over the last 25 years there have been systematic improvements in the overall survival of patients with metastatic colorectal cancer (mCRC), the median overall survival of patients has gone from 6 months to approximately 36 months.1 While 5 Flurouracil has remained at the core of treatment protocols newer chemotherapy and targeted agents and combination protocols have resulted in incremental improvements. The sequencing of the various protocols is the current challenge which still needs to be fully defined

A retrospective subset analysis of colorectal cancers at 2 centres in Johannesburg in the government and private sector : analysing of stage of patient presentation - review

Colorectal Cancer accounts for over 9% of all cancer incidence. It is the third most common cancer worldwide and is the 4th most commonest cause of death. Colorectal Cancer survival is highly dependent on earlier stage of presentation